2021 Innovation Discovery Grants (IDG) Awarded

Thursday afternoon highlights also included the awarding of six Innovation Discovery Grants (IDG) to Mass General Brigham investigators working on gene and cell therapy (GCT) advancements. Each award winner will receive $100,000 toward ongoing development and…

Our researchers receive global recognition

Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, recently shared its list of Highly Cited Researchers™ 2020. This annual list identifies researchers who demonstrated significant influence in…

Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder

Mass General Brigham Innovation Fund Licensing Agreement with Biogen to Focus on Developing Treatment for Inherited Retinal Degeneration Due to Mutations in the PRPF31 Gene July, 2, 2020: (BOSTON) – Massachusetts Eye and Ear, a member…

2021 Disruptive Dozen

The three-day forum concluded with the introduction of the Disruptive Dozen—12 new technologies identified by senior leaders from Mass General Brigham as having the chance to significantly improve healthcare in the next two years. #12 |…

Lessening the Burden of Type 1 Diabetes with Innovative Cell Therapies

By: Manasi Sinha Jaiman, M.D., M.P.H., Vice President, Clinical Development Imagine an 18-year-old walking into my office. She is looking forward to graduation.  Feeling the thrill of receiving that college acceptance letter.  Planning gatherings with friends…

Mass General Brigham Townhall Presentation

Mass General Brigham Innovation is maximizing the healthcare system’s growth strategy by investing in bold, transformative innovations and increasing commercialization opportunities. Watch an update from a recent system-wide townhall featuring Innovation team members Chris Coburn, Chief…

Recent Posts by Category

AI Insights: Cardiovascular Care

Cardiovascular diseases remain the leading cause of death worldwide and rising expense, making this area ripe for AI-enabled innovations. This AI Update includes discussions…

2021 Innovation Discovery Grants (IDG) Awarded

Thursday afternoon highlights also included the awarding of six Innovation Discovery Grants (IDG) to Mass General Brigham investigators working on gene and cell therapy…

Innovation Fellows Gain Valuable Industry Connections

The Partners Innovation Fellows Program provides up-and-coming faculty/staff physicians and investigators from Partners   with an opportunity to work with an industry partner on an…

Innovator’s Commercialization Guide

Are you an innovator with ideas that you’d like to protect and commercialize? Do you imagine working with industry to commercialize an invention? Do…

New Imaging Tools Could Reduce the Deadly Toll of Thrombus and Fibrosis

Diseases related to thrombus and fibrosis are a key contributor to strokes, heart attacks, organ failure and death and result in billions of dollars…

Realizing the Promise of AI in the Clinic

The gap between the development of AI and its use and integration in the clinic is closing, as technology, sophisticated algorithms, data sets, and…

Venture, Grants and Funds Announcements

Mass General Brigham Ventures Current Stats $450M Capital Under Management 48 Portfolio Companies 15 Exits $148M Realized & Publicly Traded   Announcements Verve Therapeutics…

A Q&A with Roger Kitterman

How do these new funds enhance the Partners Innovation Fund? These funds extend the capabilities we built with PIF.  TIF will allow us to…

Gene and Cell Therapies a Mass General Brigham System Wide Priority

In May the World Medical Innovation Forum featured panel discussions and content on cell and gene therapies across the sector. More than 20 hours…

2021 Innovation Discovery Grants (IDG) Awarded

June 2, 2021

Thursday afternoon highlights also included the awarding of six Innovation Discovery Grants (IDG) to Mass General Brigham investigators working on gene and cell therapy (GCT) advancements. Each award winner will receive $100,000 toward ongoing development and future commercialization, based on the potential to improve health outcomes, meet articulated milestones, and…

Read More

2021 Innovation Discovery Grants Awarded

May 20, 2021

Six game-changing technologies targeted at disease areas ranging from treatment of autoimmunity, to cancer, glaucoma to receive funding and Bayer mentoring. Read More: https://www.massgeneralbrigham.org/newsroom/press-releases/innovation-discovery-grants-awarded-mass-general-brigham-scientific-0 Generating Superior ‘Killers’ for Adoptive Cell Therapy in Cancer, Lydia Lynch, PhD, Brigham and Women’s Hospital Novel Strategies to Enhance Tfr Treatment of Autoimmunity, Peter Sage,…

Read More

Innovation Discovery Grants Awarded to Mass General Brigham Scientific Advancements Designed to Help Patients, Healthcare Delivery

January 6, 2021

Six disruptive scientific advancements from Mass General Brigham have been awarded Innovation Discovery Grants (IDG) in the 2020 round of awards, as the highly competitive IDG program exceeds $3.5 million in grants since inception. Each of the five potential patient health and healthcare delivery break-throughs for 2020 will receive $100,000…

Read More